Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	115.18	121.31	158.72	151.02	161.41	120.3
Short-Term Investments	-	0.59	0.82	1.48	1.76	2.52
Cash & Short-Term Investments	115.18	121.9	159.54	152.5	163.18	122.82
Cash Growth	-1.86%	-23.60%	4.62%	-6.54%	32.85%	5.80%
Accounts Receivable	129.44	102.18	95.41	96.72	72.52	55.52
Other Receivables	0.62	11.25	40.39	8.41	14.29	6.21
Receivables	130.06	113.43	135.8	105.13	86.81	61.72
Inventory	350.68	343.38	320.76	255.72	243.6	205.73
Prepaid Expenses	-	7.6	7.94	7	13.19	3.45
Other Current Assets	34.33	7.19	6.45	13.6	12.45	6.33
Total Current Assets	630.24	593.5	630.5	533.95	519.22	400.05
Property, Plant & Equipment	316.45	315.03	330.77	225.67	222.29	199.62
Long-Term Investments	21.04	21.87	25.06	36.57	105.62	60.7
Goodwill	576.46	576.38	578.52	271.32	264.73	266.27
Other Intangible Assets	504.07	406.14	441.61	212.12	217.13	235.24
Long-Term Deferred Charges	-	106.18	103.25	92.92	77.72	62.1
Other Long-Term Assets	63.48	0.94	0.97	0.28	0.27	0.41
Total Assets	2,112	2,080	2,161	1,413	1,407	1,224
Accounts Payable	97.52	94.79	86.64	56.1	52.1	50.37
Accrued Expenses	-	67.69	94.35	54.51	45.17	38.82
Short-Term Debt	-	0.04	0.01	0	-	-
Current Portion of Long-Term Debt	79.51	86.04	111.43	1.87	2.38	22.21
Current Portion of Leases	-	5.12	5	3.02	3.2	3.84
Current Income Taxes Payable	36.83	58.83	81.82	96.35	48.8	8.85
Current Unearned Revenue	-	1.5	1.43	0.56	0.62	1.06
Other Current Liabilities	92.88	12.91	13.82	5.38	3.35	7.72
Total Current Liabilities	306.74	326.92	394.49	217.79	155.61	132.87
Long-Term Debt	915.78	886.71	963.89	501.84	565.71	570.48
Long-Term Leases	-	12.35	13.25	9.72	9.01	10.28
Long-Term Unearned Revenue	-	11.34	11.69	9.2	9.46	9.72
Long-Term Deferred Tax Liabilities	112.05	111.7	112.39	50.52	36.06	29.95
Other Long-Term Liabilities	14.83	3.08	2.71	1.99	2.41	1.77
Total Liabilities	1,470	1,472	1,616	880.34	907.14	899.81
Common Stock	53.84	53.84	53.84	53.84	53.84	53.84
Retained Earnings	466.6	433.19	367.22	355.36	337.95	177.08
Comprehensive Income & Other	118.12	117.39	118.14	122.4	105.52	91.04
Total Common Equity	638.56	604.42	539.21	531.59	497.32	321.97
Minority Interest	3.67	3.87	5.84	0.9	2.52	2.62
Shareholders' Equity	642.23	608.3	545.05	532.49	499.83	324.58
Total Liabilities & Equity	2,112	2,080	2,161	1,413	1,407	1,224
Total Debt	995.29	990.26	1,094	516.45	580.3	606.8
Net Cash (Debt)	-880.11	-868.36	-934.03	-363.95	-417.13	-483.98
Net Cash Per Share	-16.34	-16.13	-17.35	-6.76	-7.75	-8.99
Filing Date Shares Outstanding	53.88	53.84	53.84	53.84	53.84	53.84
Total Common Shares Outstanding	53.88	53.84	53.84	53.84	53.84	53.84
Working Capital	323.51	266.58	236.01	316.16	363.61	267.18
Book Value Per Share	11.85	11.23	10.01	9.87	9.24	5.98
Tangible Book Value	-441.97	-378.1	-480.92	48.15	15.46	-179.54
Tangible Book Value Per Share	-8.20	-7.02	-8.93	0.89	0.29	-3.33
Land	-	247.87	252.54	171.75	163.41	147.52
Machinery	-	252.92	234.8	178.45	163.77	137.55

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.